Fda Approval Received for Her2 Image Analysis Application
Apr 24 2008
intended to be used as an aid to pathologists in detecting and quantifying HER2 protein expression from digital slide images created by Aperioâs slide scanning systems.
Aperioâs FDA clearance encompasses the companyâs complete digital pathology system, including ScanScopeÂ® scanners for creating digital slide images from microscope slides, the Spectrumâ¢ digital pathology information management system for managing, viewing, and analysing
digital slides, and the specific image analysis application which performs the automated scoring of IHC HER2 breast cancer digital slides.
Lab Asia 30.2 - April 2023
In This Edition Chromatography Articles - On-Column Sample Focussing: a Personal Perspective Mass Spectrometry & Spectroscopy Articles - Multi-scale, multi-modal and operando imaging wi...
View all digital editions
Apr 02 2023 Monterey, CA, USA
Apr 11 2023 Moscow, Russia
Microbiology Society Annual Conference 2023
Apr 17 2023 Birmingham, UK
Apr 18 2023 Kintex, South Korea
Apr 19 2023 Ho Chi Minh City, Vietnam